Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-02-09 @ 5:05 PM
Study NCT ID:
NCT00312494
Status:
COMPLETED
Last Update Posted:
2021-03-29
First Post:
2006-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-06
First Submit QC Date:
None
Study First Post Date:
2006-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-12-17
Results First Submit QC Date:
None
Results First Post Date:
2010-01-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-02
Last Update Post Date:
2021-03-29
Last Update Post Date Type:
ACTUAL